Home
Drugs
Everolimus
Clinical Trials

Clinical Trials Related to Everolimus

Related studies linked through entity extraction aliases.

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE4

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

Status: RECRUITING
Phase: EARLY_PHASE1

Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Status: UNKNOWN
Phase: PHASE2

MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

Status: NO_LONGER_AVAILABLE
Phase: N/A

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients

Status: UNKNOWN
Phase: PHASE4

Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial)

Status: UNKNOWN
Phase: PHASE4

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Status: RECRUITING
Phase: PHASE2

The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient

Status: RECRUITING
Phase: NA

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Status: SUSPENDED
Phase: PHASE1

Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

Status: UNKNOWN
Phase: PHASE2

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Status: COMPLETED
Phase: PHASE1/PHASE2

Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

Status: TERMINATED
Phase: PHASE3

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Status: RECRUITING
Phase: NA

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3